Testosteron (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Testosteron" in Polish language version.

Last modified:

Ref.Un. Ref.Website
Global rank Polish rank
5th place
7th place
2nd place
5th place
low place
low place
low place
low place
6,008th place
low place
774th place
132nd place
265th place
173rd place
470th place
1,178th place

antydoping.pl (Global: low place; Polish: low place)

doi.org (Global: 2nd place; Polish: 5th place)

  • Eberhard Nieschlag, Susan Nieschlag, ENDOCRINE HISTORY: The history of discovery, synthesis and development of testosterone for clinical use, „European Journal of Endocrinology”, 180 (6), 2019, R201–R212, DOI: 10.1530/EJE-19-0071 (ang.).
  • Joel S. Finkelstein i inni, Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men, „The New England Journal of Medicine”, 369 (11), 2013, s. 1011–1022, DOI: 10.1056/NEJMoa1206168, PMID: 24024838 (ang.).
  • Peter J. Snyder i inni, Lessons From the Testosterone Trials, „Endocrine Reviews”, 39 (3), 2018, s. 369–386, DOI: 10.1210/er.2017-00234, PMID: 29522088 (ang.).
  • Peter J. Snyder i inni, Testosterone Treatment and Fractures in Men with Hypogonadism, „The New England Journal of Medicine”, 390 (3), 2024, s. 203–211, DOI: 10.1056/NEJMoa2308836, PMID: 38231621 (ang.).
  • Eric Bachman i inni, Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point, „The Journals of Gerontology: Series A”, 69 (6), 2014, s. 725–735, DOI: 10.1093/gerona/glt154, PMID: 24158761 (ang.).
  • S.N. Geniole i inni, Is testosterone linked to human aggression? A meta-analytic examination of the relationship between baseline, dynamic, and manipulated testosterone on human aggression, „Hormones and Behavior”, 123, 2020, s. 104644, DOI: 10.1016/j.yhbeh.2019.104644, PMID: 31785281 (ang.).
  • Susan M. Resnick i inni, Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment, „Journal of the American Medical Association”, 317 (7), 2017, s. 717–727, DOI: 10.1001/jama.2016.21044, PMID: 28241356 (ang.).
  • Susan R. Davis i inni, Global Consensus Position Statement on the Use of Testosterone Therapy for Women, „The Journal of Clinical Endocrinology & Metabolism”, 104 (10), 2019, s. 4660–4666, DOI: 10.1210/jc.2019-01603, PMID: 31498871 (ang.).
  • Shalender Bhasin i inni, Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline, „The Journal of Clinical Endocrinology & Metabolism”, 103 (5), 2018, s. 1715–1744, DOI: 10.1210/jc.2018-00229, PMID: 29562364 (ang.).
  • Giovanni Corona i inni, EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism, „European Urology Focus”, 2026, DOI: 10.1016/j.euf.2026.04.015, PMID: 42177105 (ang.).
  • Helena J. Teede i inni, Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, „The Journal of Clinical Endocrinology & Metabolism”, 108 (10), 2023, s. 2447–2469, DOI: 10.1210/clinem/dgad463, PMID: 37580314 (ang.).
  • Sharon J. Parish i inni, International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women, „Journal of Women's Health”, 30 (4), 2021, s. 474–491, DOI: 10.1089/jwh.2021.29037, PMID: 33797277 (ang.).
  • Wylie C. Hembree i inni, Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline, „The Journal of Clinical Endocrinology & Metabolism”, 102 (11), 2017, s. 3869–3903, DOI: 10.1210/jc.2017-01658, PMID: 28945902 (ang.).
  • A. Michael Lincoff i inni, Cardiovascular Safety of Testosterone-Replacement Therapy, „The New England Journal of Medicine”, 389 (2), 2023, s. 107–117, DOI: 10.1056/NEJMoa2215025, PMID: 37326322 (ang.).
  • Shalender Bhasin i inni, Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial, „JAMA Network Open”, 6 (12), 2023, e2348692, DOI: 10.1001/jamanetworkopen.2023.48692, PMID: 38150256 (ang.).

fda.gov (Global: 470th place; Polish: 1,178th place)

hhs.gov (Global: 6,008th place; Polish: low place)

nih.gov (Global: 5th place; Polish: 7th place)

ncbi.nlm.nih.gov

  • David J. Handelsman, Androgen Physiology, Pharmacology, Use and Misuse [online], Endotext, NCBI Bookshelf, 5 października 2020 [dostęp 2026-10-24] (ang.).
  • Iain J. McEwan, Albert O. Brinkmann, Androgen Physiology: Receptor and Metabolic Disorders [online], Endotext, NCBI Bookshelf, 2 lipca 2021 [dostęp 2026-10-24] (ang.).
  • Liza O’Donnell, Lee B. Smith, Endocrinology of the Testis and Spermatogenesis [online], Endotext, NCBI Bookshelf, 7 stycznia 2026 [dostęp 2026-10-24] (ang.).
  • Joel S. Finkelstein i inni, Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men, „The New England Journal of Medicine”, 369 (11), 2013, s. 1011–1022, DOI: 10.1056/NEJMoa1206168, PMID: 24024838 (ang.).
  • Peter J. Snyder i inni, Lessons From the Testosterone Trials, „Endocrine Reviews”, 39 (3), 2018, s. 369–386, DOI: 10.1210/er.2017-00234, PMID: 29522088 (ang.).
  • Peter J. Snyder i inni, Testosterone Treatment and Fractures in Men with Hypogonadism, „The New England Journal of Medicine”, 390 (3), 2024, s. 203–211, DOI: 10.1056/NEJMoa2308836, PMID: 38231621 (ang.).
  • Eric Bachman i inni, Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point, „The Journals of Gerontology: Series A”, 69 (6), 2014, s. 725–735, DOI: 10.1093/gerona/glt154, PMID: 24158761 (ang.).
  • S.N. Geniole i inni, Is testosterone linked to human aggression? A meta-analytic examination of the relationship between baseline, dynamic, and manipulated testosterone on human aggression, „Hormones and Behavior”, 123, 2020, s. 104644, DOI: 10.1016/j.yhbeh.2019.104644, PMID: 31785281 (ang.).
  • Susan M. Resnick i inni, Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment, „Journal of the American Medical Association”, 317 (7), 2017, s. 717–727, DOI: 10.1001/jama.2016.21044, PMID: 28241356 (ang.).
  • Susan R. Davis i inni, Global Consensus Position Statement on the Use of Testosterone Therapy for Women, „The Journal of Clinical Endocrinology & Metabolism”, 104 (10), 2019, s. 4660–4666, DOI: 10.1210/jc.2019-01603, PMID: 31498871 (ang.).
  • Shalender Bhasin i inni, Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline, „The Journal of Clinical Endocrinology & Metabolism”, 103 (5), 2018, s. 1715–1744, DOI: 10.1210/jc.2018-00229, PMID: 29562364 (ang.).
  • Giovanni Corona i inni, EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism, „European Urology Focus”, 2026, DOI: 10.1016/j.euf.2026.04.015, PMID: 42177105 (ang.).
  • Helena J. Teede i inni, Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, „The Journal of Clinical Endocrinology & Metabolism”, 108 (10), 2023, s. 2447–2469, DOI: 10.1210/clinem/dgad463, PMID: 37580314 (ang.).
  • Sharon J. Parish i inni, International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women, „Journal of Women's Health”, 30 (4), 2021, s. 474–491, DOI: 10.1089/jwh.2021.29037, PMID: 33797277 (ang.).
  • Wylie C. Hembree i inni, Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline, „The Journal of Clinical Endocrinology & Metabolism”, 102 (11), 2017, s. 3869–3903, DOI: 10.1210/jc.2017-01658, PMID: 28945902 (ang.).
  • A. Michael Lincoff i inni, Cardiovascular Safety of Testosterone-Replacement Therapy, „The New England Journal of Medicine”, 389 (2), 2023, s. 107–117, DOI: 10.1056/NEJMoa2215025, PMID: 37326322 (ang.).
  • Shalender Bhasin i inni, Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial, „JAMA Network Open”, 6 (12), 2023, e2348692, DOI: 10.1001/jamanetworkopen.2023.48692, PMID: 38150256 (ang.).

pubchem.ncbi.nlm.nih.gov

  • Testosterone (CID 6013) [online], PubChem, National Center for Biotechnology Information [dostęp 2026-10-24] (ang.).

nobelprize.org (Global: 265th place; Polish: 173rd place)

sigmaaldrich.com (Global: 774th place; Polish: 132nd place)

  • Testosteron [PDF], karta charakterystyki produktu Sigma-Aldrich, Merck, 9 października 2021, numer katalogowy: 86500 [dostęp 2022-06-23].

uroweb.org (Global: low place; Polish: low place)